• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

COVID-19 Fact vs Fiction: 9 Myth-busting Answers from the World Health Organization

Slideshow

Fact or fiction? Vaccines against pneumonia can protect against COVID-19. Plus 8 more questions and answers from the World Health Organization.

Can ultraviolet lamps kill the novel coronavirus disease 2019 (COVID-19)? Can COVID-19 be spread through mosquito bites? These questions may seem a bit outlandish, but between fraudulent products being sold online that promise a cure and misinformation circulating across social media, it can be hard for patients to decipher which information regarding COVID-19 is real or fake. The World Health Organization (WHO) compiled answers to some of the most common questions and thoughts to help educate the public on what the latest evidence shows regarding COVID-19. Scroll through the brief slideshow below based on the WHO's list to see if you know which statements on COVID-19 are true or just plain fiction.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
Decrease in BMI Linked to Increased Risk for Severe Exacerbations, All-Cause Mortality in COPD / image credit weight loss/gain: ©missbobbit/stock.adobe.com

Decrease in BMI Linked to Increased Risk for Severe Exacerbations, All-Cause Mortality in COPD

April 19th 2024
Article

Among persons with COPD whose BMI decreased over a 4-year follow-up, mortality risk rose 70% compared with those whose BMI remained the same, researchers reported.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

RSV Disease Severity Comparable to Unvaccinated COVID-19, Flu: Daily Dose / image credit: ©New Africa/AdobeStock

RSV Disease Severity Comparable to Unvaccinated COVID-19, Flu: Daily Dose

April 18th 2024
Article

Your daily dose of the clinical news you may have missed.

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care

August 30th 2023
Podcast

Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.

Navigating the New Wave of Antiobesity Medications: What Primary Care Clinicians Should Know / Image credit: ©Antonio Diaz/AdobeStock

Navigating the New Wave of Antiobesity Medications: What Primary Care Clinicians Should Know

April 17th 2024
Article

With the rise in demand for newer antiobesity medications, clinicians may face more questions from patients. Here, a primer on the drawbacks and benefits to keep in mind.

Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Regulatory Submission / image credit obese man asleep / ©motortion/stock.adobe.com

Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Mid-2024 Regulatory Submission

April 17th 2024
Article

Tirzepatide reduced OSA symptoms and body weight in study participants with severe OSA and obesity, regardless of use of positive airway pressure therapy.

© 2024 MJH Life Sciences

All rights reserved.